Misplaced Pages

Z4349

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
Z4349
Identifiers
IUPAC name
  • (5S)-5-amino]-1-hydroxyethyl]-1-(2-chlorobenzyl)pyrrolidin-2-one
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC21H33ClN2O2
Molar mass380.96 g·mol
3D model (JSmol)
SMILES
  • CC(C)N(C(1CCC(=O)N1CC2=CC=CC=C2Cl)O)(C)CC
InChI
  • InChI=1S/C21H33ClN2O2/c1-5-15(3)23(16(4)6-2)14-20(25)19-11-12-21(26)24(19)13-17-9-7-8-10-18(17)22/h7-10,15-16,19-20,25H,5-6,11-14H2,1-4H3/t15-,16-,19+,20+/m1/s1
  • Key:YNGZJSALRCLELM-YKCBXCCJSA-N

Z4349 is an opioid analgesic drug developed in the 1990s by the pharmaceutical company Zambon. It is a derivative of an older drug viminol, which has been modified to improve potency and metabolic stability. In tests on mice it was found to be several hundred times the potency of morphine.

Synthesis

Z4349 synthesis

Esterification of L-glutamic acid (1) with ethanol gives Glutamic acid diethyl ester (2). Lactam formation occurs on heating to give L-Pyroglutamic acid ethyl ester (3). The reduction of the ester with sodium borohydride gives L-Pyroglutaminol (4). Treatment with methyl chloride gave (S)-(5-Oxopyrrolidin-2-yl)methyl methanesulfonate (5). Displacement of the leaving group with cyanide led to (S)-5-Oxo-2-pyrrolidineacetonitrile (6). Catalytic reduction over Rosenmund catalyst in the presence of dimethylamine led to (5S)-5-pyrrolidin-2-one, PC13306712 (7). Oxidation in the presence of hydrogen peroxide formed the N-oxide (8). Elimination of the amino group in the presence of weak base led to (S)-5-Vinylpyrrolidin-2-one (9). Alkylation of the amino group with 2-Chlorobenzyl chloride (10) in the presence of sodium hydride base led to (5S)-1--5-ethenylpyrrolidin-2-one, PC56976994 (11). Treatment of the vinyl group with peroxy acid gave the oxirane. (5S)-1--5-(oxiran-2-yl)pyrrolidin-2-one, PC88496451 (12). Treatment with (2R)-N-butan-2-amine, PC6347588 (13) completed the synthesis of Z4349 (14).

See also

References

  1. US 4960788, Carenzi A, Chiarino D, Bella DD, Grancini GC, Veneziani C, "Pyrrolidone-2 compounds and their use for central analgesic activity", issued 2 October 1990, assigned to Zambon Group S.P.A. 
  2. Napoletano M, Delia BD, Fraire C, Grancini G, Masotto C, Ricciardi S, Zambon C (1995). "Stereoselective synthesis and evaluation of all stereoisomers of Z4349, a novel and selective μ-opioid analgesic". Bioorganic & Medicinal Chemistry Letters. 5 (6): 589–592. doi:10.1016/0960-894X(95)00077-7.


Opioid receptor modulators
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
  • Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)


Stub icon

This analgesic-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: